1019 ET - CrowdStrike's 1Q was an expectations miss, UBS analysts say in a research note. With net new annual recurring revenue of $256 million coming in below investor hopes "and 2% beat coming in well below the fairly steady cadence of 10%+ beats over the past few quarters," the analysts say the main debate from here will be around "beat cadence" going forward. That said, management spoke about a record pipeline and significantly increased the 2Q/FY NNARR outlook, according to the analysts. They add that they expect Anthropic's Mythos to ultimately be a tailwind to cybersecurity spend. UBS maintains its buy rating and raises its price target to $790 from $525. CrowdStrike is off 7% to $693.97. (connor.hart@wsj.com)

(END) Dow Jones Newswires

June 04, 2026 10:19 ET (14:19 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.